ERCC1 and lung carcinoma: First, we compared the expression of six molecular biomarkers (MDR-1, LRP, RRM-1, EGFR, ERCC-1, and BRCA-1) in the primary lung carcinoma and the metastatic lymph nodes of patients with the two subtypes of NSCLC (Table 2).